A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression
Clinical trial NCT07053345 · COMPLETED
Trial details
- NCT number
- NCT07053345
- Sponsor
- Janssen Korea, Ltd., Korea
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-09
- Primary completion
- 2026-07-13
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.